What does the new era of Parkinson’s research mean, and what’s next — for research, and for those living with the disease? From the new biomarker for PD discovered last spring, to discussions of biological staging for disease and new therapeutics accelerating through the clinical pipeline, it’s a year like no other for Parkinson’s research. Tune in to hear from MJFF scientists and staff on why this year is transformative — and why we’re entering a new era.